Start-up
Abviris Deutschland GmbH
Oral cancer early detection. Simple, effective and fast.
About Abviris
The development, manufacture and marketing of innovative in vitro diagnostics and medical devices with the aim of avoiding or alleviating the human papillomavirus (HPV) caused cancer diseases is our mission. Our core competency is in the use of immunological active components, such as a wide range of unique antibodies against different HP viruses and specific antigens. In Germany was the market launch of our first product the Prevo-Check® quick test in the early 2015 This in vitro diagnostic tool and represents the world's first commercially available method for specific screening of HPV-associated oral cavity carcinomas. Abviris Deutschland GmbH was founded in March 2014 by Dr. Ralf Hilfrich. The German market was in Frankfurt/Main the starting point of the company.
- Focus : Manufacturer
- Industry : Diagnostics
Product portfolio of Abviris
Here you will find Abviris Deutschland GmbH
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
